ASCO 2022 | Bladder-sparing approaches in muscle-invasive urothelial carcinoma

Name: Bladder-sparing approaches in muscle-invasive urothelial carcinoma
Uploaded: 2022-06-05T00:00:00Z
Duration: 37 s
Description: Richard Cathomas, MD, PhD, Hospital Graubünden, Chur, Switzerland, highlights the importance of bladder-sparing approaches in advanced muscle-invasive bladder cancer as well as other areas of unmet needs in this patient population. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

Richard Cathomas • 5 Jun 2022

ASCO 2022

Bladder Cancer Genitourinary Cancer

Richard Cathomas, MD, PhD, Hospital Graubünden, Chur, Switzerland, highlights the importance of bladder-sparing approaches in advanced muscle-invasive bladder cancer as well as other areas of unmet needs in this patient population. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.